Zacks Market Edge Highlights: Smartsheet, DocuSign, Domo, Dropbox and Zscaler

For Immediate Release

Chicago, IL – April 23, 2019 – Zacks Market Edge is a podcast hosted weekly by cks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:

(Please use the Soundcloud link from this URL for the PR. Thanks:

IPO Deja Vu: Is It 1999 All Over Again?

Welcome to Episode #173 of the Zacks Market Edge Podcast.

Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.

In this episode, Tracey is joined by Zacks Senior Strategist, Kevin Cook, to take a walk back into the past.

The Golden Year of the Dot-Com Boom

Remember the investing world in 1999?

Not only was the NASDAQ soaring but the IPO market was the hottest it had ever been.

In 1998 there were 363 deals and, in 1999, that jumped to an all-time record of 510 IPOs.

By comparison, in 2018, just 190 deals were done although 2018 was considered a “good” year.

By the end of 1999, it wasn’t unusual for some of the shares to have jumped over 400% since their launch. One of the big IPOs, VA Linux Systems, soared 698% in a matter of weeks.

Everyone wanted in, from grandmothers trading at their computers to institutional funds.

Now, flash forward to 2019, where a bunch of popular private technology companies are set to go public, such as Uber and Pinterest, many of them without any earnings.

Is this a replay of 1999 all over again?

Look at Last Year’s IPOs Instead

If you’re nervous about jumping into 2019’s batch of IPOs, why not take a look at 2018 before the Street got interested?

Kevin has his list of names, and why he does or doesn’t like them, including 5 technology names such as Smartsheet SMAR, DocuSign DOCU, Domo DOMO, Dropbox DBX and Zscaler ZS.

These companies have a track record now, with a couple of quarters of earnings reports under their belt.

What else should you know about the IPO boom and how to invest in it?

Listen to this week’s podcast to find out.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Follow us on Twitter:

Join us on Facebook:

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.

Click to get this free report

Smartsheet Inc. (SMAR): Free Stock Analysis Report

Dropbox, Inc. (DBX): Free Stock Analysis Report

Zscaler, Inc. (ZS): Free Stock Analysis Report

Domo, Inc. (DOMO): Free Stock Analysis Report

DocuSign Inc. (DOCU): Free Stock Analysis Report

To read this article on click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.